The plasma hemostatic proteome: thrombin generation in healthy individuals

被引:69
作者
Brummel-Ziedins, K
Vossen, CY
Rosendaal, FR
Umezaki, K
Mann, KG
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, Leiden, Netherlands
关键词
coagulation; factor levels; numerical simulators; thrombin profiles; risk factors;
D O I
10.1111/j.1538-7836.2005.01249.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: The range of plasma concentrations of hemostatic analytes in the population is wide, In this study these components of blood coagulation phenotype are integrated in an attempt to predict clinical risk. Methods: We modeled tissue factor (TF)-induced thrombin generation in the control population (N = 473) from the Leiden Thrombophilia Study utilizing a numerical simulation model. Hypothetical thrombin generation Curves were established by modeling pro- and anticoagulant factor levels for each individual. These curves were evaluated using parameters which describe the initiation, propagation and termination phases of thrombin generation, i.e. time to 10 nm thrombin (approximate clot time), total thrombin and the maximum rates and levels of thrombin generated. Results and conclusions: The time to 10 nm thrombin varied over a 3-fold range (2.9-9.5 min), maximum levels varied over a similar to 4-fold range (200-800 rim), maximum rates varied similar to 4.8-fold (90-435 nM min(-1)) and total thrombin varied similar to 4.5-fold (39-177 mu M s(-1)) within this control population. Thrombin generation curves, defined by the clotting factor concentrations, were distinguished by sex, age, body mass index (BMI) and oral contraceptive (OC) use. Our results show that the capacity for thrombin generation in response to a TF challenge may represent a method to identify an individual's propensity for developing thrombosis.
引用
收藏
页码:1472 / 1481
页数:10
相关论文
共 62 条
[51]   Physical activity in the prevention and treatment of a thrombogenic profile in the obese:: current evidence and research issues [J].
Rauramaa, R ;
Väisänen, SB .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (11) :S631-S634
[52]  
Reiner AP, 2001, THROMB HAEMOSTASIS, V85, P584
[53]   Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women [J].
Romano, M ;
Guagnano, MT ;
Pacini, G ;
Vigneri, S ;
Falco, A ;
Marinopiccoli, M ;
Manigrasso, MR ;
Basili, S ;
Davì, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5321-5326
[54]   Estrogens, progestogens and thrombosis [J].
Rosendaal, FR ;
Vlieg, AV ;
Tanis, BC ;
Helmerhorst, FM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1371-1380
[55]   Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives [J].
Rosing, J ;
Tans, G ;
Nicolaes, GAF ;
Thomassen, MCLGD ;
vanOerle, R ;
vanderPloeg, PMEN ;
Heijnen, P ;
Hamulyak, K ;
Hemker, HC .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (01) :233-238
[56]   Effects of oral contraceptives on hemostasis and thrombosis [J].
Rosing, J ;
Tans, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (06) :S375-S382
[57]   Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation [J].
Sorensen, B ;
Johansen, P ;
Christiansen, K ;
Woelke, M ;
Ingerslev, J .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :551-558
[58]   Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa [J].
van't Veer, C ;
Golden, NJ ;
Mann, KG .
BLOOD, 2000, 95 (04) :1330-1335
[59]  
vanBoven HH, 1997, SEMIN HEMATOL, V34, P188
[60]  
vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631